Regulation of cardiac nitric oxide signaling by nuclear β-adrenergic and endothelin receptors

Journal of Molecular and Cellular Cardiology

Volumn 62, Issue , 2013, Pages 58-68

  Vaniotis, George ^a,b   Glazkova, Irina ^c   Merlen, Clémence ^a,b   Smith, Carter ^c   Villeneuve, Louis R ^b   Chatenet, David ^d   Therien, Michel ^c   Fournier, Alain ^d   Tadevosyan, Artavazd ^a,b   Trieu, Phan ^c   Nattel, Stanley ^b,c   Hébert, Terence E ^c   Allen, Bruce G ^a,b,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

Adrenergic receptors; Endothelin receptors; Nitric oxide; Nuclear membranes; Protein kinase G; Transcription

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CELL NUCLEUS RECEPTOR; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; ENDOTHELIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANYLATE CYCLASE; ISOPRENALINE; KT 5823; N (2 NITROBENZYL)ISOPROTERENOL; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; UNCLASSIFIED DRUG; XAMOTEROL;

ADULT ANIMAL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; HEART MUSCLE CELL; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

Α-ADRENERGIC RECEPTOR; ΑAR; Β-ADRENERGIC RECEPTOR; Β-ADRENERGIC RECEPTORS; ΒAR; AC; ADENOSINE TRIPHOSPHATE; ADENYLYL CYCLASE; ATP; CAGED ET-1; CET-1; CGMP; CYANOPINDOLOL; CYCLIC GUANOSINE 3′,5′-MONOPHOSPHATE; CYP; DAF-2; DEOXYRIBONUCLEIC ACID; DIAMINOFLUORESCEIN-2; DITHIOTHREITOL; DNA; DTT; EEDQ; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTORS; ENDOTHELIN TYPE B RECEPTOR; ET-1; ETB; ETR; G PROTEIN-COUPLED RECEPTOR; GC; GPCR; GUANYLYL CYCLASE; ISO; ISOPROTERENOL; N-ETHOXYCARBONYL-2-ETHOXY-1,2-DIHYDROQUINOLINE; NFΚB; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NO; NOS; NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B-CELLS; NUCLEAR MEMBRANES; NUCLEOPORIN 62; NUP62; PBS; PERTUSSIS TOXIN; PHENYLMETHANESULFONYLFLUORIDE; PHOSPHATE BUFFERED SALINE; PHOSPHOINOSITIDE 3-KINASE; PI3K; PKB; PKG; PMSF; PROTEIN KINASE B; PROTEIN KINASE G; PTX; QPCR; QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION; RIBONUCLEIC ACID; RNA; TCA; TRANSCRIPTION; TRICHLOROACETIC ACID; TRITON X-100; TX-100; URIDINE 5(′) TRIPHOSPHATE; UTP;

ANIMALS; ENDOTHELIN-1; ISOPROTERENOL; MALE; MYOCYTES, CARDIAC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ENDOTHELIN; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84878688815     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.05.003     Document Type: Article

References (54)

1. Tadevosyan A., Vaniotis G., Allen B.G., Hébert T.E., Nattel S. G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function. J Physiol 2012, 590:1313-1330.
2. Vaniotis G., Allen B.G., Hébert T.E. Nuclear GPCRs in cardiomyocytes: an insider's view of β-adrenergic receptor signaling. Am J Physiol Heart Circ Physiol 2011, 301:H1754-H1764.
3. Boivin B., Chevalier D., Villeneuve L.R., Rousseau E., Allen B.G. Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J Biol Chem 2003, 278:29153-29163.
4. Boivin B., Lavoie C., Vaniotis G., Baragli A., Villeneuve L.R., Ethier N., et al. Functional β-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. Cardiovasc Res 2006, 71:69-78.
5. Sastri M., Barraclough D.M., Carmichael P.T., Taylor S.S. A-kinase-interacting protein localizes protein kinase A in the nucleus. Proc Natl Acad Sci U S A 2005, 102:349-354.
6. Willard F.S., Crouch M.F. Nuclear and cytoskeletal translocation and localization of heterotrimeric G-proteins. Immunol Cell Biol 2000, 78:387-394.
7. Vaniotis G., Del Duca D., Trieu P., Rohlicek C.V., Hébert T.E., Allen B.G. Nuclear β-adrenergic receptors modulate gene expression in adult rat heart. Cell Signal 2011, 23:89-98.
8. Loscalzo J., Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 1995, 38:87-104.
9. Hammond J., Balligand J.L. Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: from contractility to remodeling. J Mol Cell Cardiol 2012, 52:330-340.
10. Moens A.L., Yang R., Watts V.L., Barouch L.A. Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system. J Mol Cell Cardiol 2010, 48:1088-1095.
11. Zhang Y.H., Casadei B. Sub-cellular targeting of constitutive NOS in health and disease. J Mol Cell Cardiol 2012, 52:341-350.
12. Hayashi Y., Nishio M., Naito Y., Yokokura H., Nimura Y., Hidaka H., et al. Regulation of neuronal nitric-oxide synthase by calmodulin kinases. J Biol Chem 1999, 274:20597-20602.
13. Hu J., el-Fakahany E.E. Intricate regulation of nitric oxide synthesis in neurons. Cell Signal 1996, 8:185-189.
14. Martins A.R., Zanella C.A., Zucchi F.C., Dombroski T.C., Costa E.T., Guethe L.M., et al. Immunolocalization of nitric oxide synthase isoforms in human archival and rat tissues, and cultured cells. J Neurosci Methods 2011, 198:16-22.
15. Siednienko J., Nowak J., Moynagh P.N., Gorczyca W.A. Nitric oxide affects IL-6 expression in human peripheral blood mononuclear cells involving cGMP-dependent modulation of NF-kappaB activity. Cytokine 2011, 54:282-288.
16. Dawn B., Bolli R. Role of nitric oxide in myocardial preconditioning. Ann N Y Acad Sci 2002, 962:18-41.
17. Mao M., Sudhahar V., Ansenberger-Fricano K., Fernandes D.C., Tanaka L.Y., Fukai T., et al. Nitroglycerin drives endothelial nitric oxide synthase activation via the phosphatidylinositol 3-kinase/protein kinase B pathway. Free Radic Biol Med 2012, 52:427-435.
18. Savard M., Barbaz D., Belanger S., Muller-Esterl W., Bkaily G., D'Orleans-Juste P., et al. Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation. J Cell Physiol 2008, 216:234-244.
19. 3 receptors. Circ Res 2002, 90:682-689.
20. Gobeil F., Zhu T., Brault S., Geha A., Vazquez-Tello A., Fortier A., et al. Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes iNOS and mPGES-1. J Biol Chem 2006, 281:16058-16067.
21. Strijdom H., Friedrich S.O., Hattingh S., Chamane N., Lochner A. Hypoxia-induced regulation of nitric oxide synthase in cardiac endothelial cells and myocytes and the role of the PI3-K/PKB pathway. Mol Cell Biochem 2009, 321:23-35.
22. Kapakos G., Bouallegue A., Daou G.B., Srivastava A.K. Modulatory role of nitric oxide/cGMP system in endothelin-1-induced signaling responses in vascular smooth muscle cells. Curr Cardiol Rev 2010, 6:247-254.
23. Kanai A.J., Mesaros S., Finkel M.S., Oddis C.V., Birder L.A., Malinski T. Beta-adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes. Am J Physiol 1997, 273:C1371-C1377.
24. Provost C., Choufani F., Avedanian L., Bkaily G., Gobeil F., Jacques D. Nitric oxide and reactive oxygen species in the nucleus revisited. Can J Physiol Pharmacol 2010, 88:296-304.
25. Muralidharan S., Nerbonne J.M. Photolabile "caged" adrenergic receptor agonists and related model compounds. J Photochem Photobiol B 1995, 27:123-137.
26. Tadevosyan A., Maguy A., Villeneuve L.R., Babin J., Bonnefoy A., Allen B.G., et al. Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression. J Biol Chem 2010, 285:22338-22349.
27. Lemire I., Allen B.G., Rindt H., Hebert T.E. Cardiac-specific overexpression of alpha1BAR regulates betaAR activity via molecular crosstalk. J Mol Cell Cardiol 1998, 30:1827-1839.
28. Boivin B., Allen B.G. Regulation of membrane-bound PKC in adult cardiac ventricular myocytes. Cell Signal 2003, 15:217-224.
29. Bourgault S., Letourneau M., Fournier A. Development of photolabile caged analogs of endothelin-1. Peptides 2007, 28:1074-1082.
30. Masri B., Salahpour A., Didriksen M., Ghisi V., Beaulieu J.M., Gainetdinov R.R., et al. Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics. Proc Natl Acad Sci U S A 2008, 105:13656-13661.
31. Chevalier D., Allen B.G. Two distinct forms of MAPKAP kinase-2 in adult cardiac ventricular myocytes. Biochemistry 2000, 39:6145-6156.
32. Jaureguiberry M.S., di Nunzio A.S., Dattilo M.A., Bianciotti L.G., Vatta M.S. Endothelin 1 and 3 enhance neuronal nitric oxide synthase activity through ETB receptors involving multiple signaling pathways in the rat anterior hypothalamus. Peptides 2004, 25:1133-1138.
33. Bhattacharya M., Peri K., Ribeiro-da-Silva A., Almazan G., Shichi H., Hou X., et al. Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope. J Biol Chem 1999, 274:15719-15724.
34. Gobeil F., Bernier S.G., Vazquez-Tello A., Brault S., Beauchamp M.H., Quiniou C., et al. Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1. J Biol Chem 2003, 278:38875-38883.
35. John T.A., Ibe B.O., Raj J.U. Regulation of endothelial nitric oxide synthase: involvement of protein kinase G 1β, serine 116 phosphorylation and lipid structures. Clin Exp Pharmacol Physiol 2008, 35:148-158.
36. John T.A., Raj J.U. A fluorescence-activated cell sorter analysis of the relationship between protein kinase G and endothelial nitric oxide synthase. Anat Rec (Hoboken) 2010, 293:1755-1765.
37. Lavoie C., Hebert T.E. Pharmacological characterization of putative beta1-beta2-adrenergic receptor heterodimers. Can J Physiol Pharmacol 2003, 81:186-195.
38. Brunner F., Brás-Silva C., Cerdeira A.S., Leite-Moreira A.F. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther 2006, 111:508-531.
39. Penna C., Rastaldo R., Mancardi D., Cappello S., Pagliaro P., Westerhof N., et al. Effect of endothelins on the cardiovascular system. J Cardiovasc Med (Hagerstown) 2006, 7:645-652.
40. 2-adrenergic receptors after down-regulation or irreversible blockade. Mol Pharmacol 1986, 30:104-111.
41. Muraski J.A., Fischer K.M., Wu W., Cottage C.T., Quijada P., Mason M., et al. Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload. Proc Natl Acad Sci U S A 2008, 105:13889-13894.
42. Zhang Y., Wang Z., Li X., Magnuson N.S. Pim kinase-dependent inhibition of c-Myc degradation. Oncogene 2008, 27:4809-4819.
43. 1- and β-adrenergic receptors. J Mol Cell Cardiol 1993, 25:1037-1046.
44. Wright C.D., Chen Q., Baye N.L., Huang Y., Healy C.L., Kasinathan S., et al. Nuclear α1-adrenergic receptors signal activated ERK localization to caveolae in adult cardiac myocytes. Circ Res 2008, 103:992-1000.
45. Jacques D., Descorbeth M., Abdel-Samad D., Provost C., Perreault C., Jules F. The distribution and density of ET-1 and its receptors are different in human right and left ventricular endocardial endothelial cells. Peptides 2005, 26:1427-1435.
46. Balligand J.L., Ungureanu-Longrois D., Simmons W.W., Pimental D., Malinski T.A., Kapturczak M., et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 1994, 269:27580-27588.
47. Sun J., Morgan M., Shen R.F., Steenbergen C., Murphy E. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res 2007, 101:1155-1163.
48. Prieto C.P., Krause B.J., Quezada C., San Martin R., Sobrevia L., Casanello P. Hypoxia-reduced nitric oxide synthase activity is partially explained by higher arginase-2 activity and cellular redistribution in human umbilical vein endothelium. Placenta 2011, 32:932-940.
49. Zhen M.F., Chen J.Y., Liu F., Dong S.M., He Y.J., Zhu Q.K., et al. The operative technique selection of lung transplantation for end-stage emphysema. Zhonghua Wai Ke Za Zhi 2005, 43:1444-1446.
50. i/o-Src kinase-PI3K/Akt pathway and caveolin-1 in β-adrenoceptor coupling to endothelial NO synthase in mouse pulmonary artery. Cell Signal 2011, 23:1136-1143.
51. Datar R., Kaesemeyer W.H., Chandra S., Fulton D.J., Caldwell R.W. Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx. Br J Pharmacol 2010, 160:1765-1772.
52. Zheng M., Zhu W., Han Q., Xiao R.P. Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling. Pharmacol Ther 2005, 108:257-268.
53. Dossumbekova A., Berdyshev E.V., Gorshkova I., Shao Z., Li C., Long P., et al. Akt activates NOS3 and separately restores barrier integrity in H2O2-stressed human cardiac microvascular endothelium. Am J Physiol Heart Circ Physiol 2008, 295:H2417-H2426.
54. Wright C.D., Wu S.C., Dahl E.F., Sazama A.J., O'Connell T.D. Nuclear localization drives α1-adrenergic receptor oligomerization and signaling in cardiac myocytes. Cell Signal 2012, 24:794-802.